Grant

New Jersey Commission on Science, Innovation and Technology (CSIT) has awarded VITRUVIAE a seed grant to investigate the use of lead product VIT-GLT, a pan-tumor and pan-viral targeting therapeutic molecule, for the treatment of viral infections that affect maternal and infant health.

Full press release can be accessed here.